HS rxns, transplant, cell migration (Ben) Flashcards
Examples of Type III HS rxns
Ab-Ag complex mediated…
- SLE - anti-RNP and anti-cardiolipin Abs
- Rheumatoid Arthritis - rheumatoid factor Ab
- Serum Sickness - Abs against anti-venom, etc.
- Penicillin Allergy - binds to RBCs –> Ab binding
- Arthus Reaction - local reaction to injected proteins
Examples of Type II HS rxns
IgG against cell surface/matrix antigens…
Cytotoxic:
- Rh incompatibility: erythroblastosis fetalis
- Drug hypersensitivity: ex: penicillin –> RBC –> IgG
Non-cytotoxic:
- Graves/Basedow: TSH-R Ab stimulates T3/T4 release
- Myasthenia Gravis: anti-nAChR Ab
Examples of Type IV HS rxns…
2-3 day delayed, T-cell mediated…
- Contact Dermatitis: poison ivy complexes with skin proteins –> APCs activate T cells –> memory Ts react to poison ivy/skin complex quickly next time (also via Ni)
- Multiple Sclerosis: T cells against myelin basic protein
- Hashimoto’s: hypothyroidism, unknown thyroid Ag
- Type I DM
- Celiac: rxn against de-amidated gliadin
5 results of complement activation
- Lysis - via MAC formation
- Opsonization - C4b/3b -> CR1-mediated phagocytosis
- Inflammation - C3a/4a/5a anaphylatoxins
- B cell activation - C3d binds CR2 on B cells
- Immune Complex Clearance - RBCs carry C3b bound complexes to spleen/liver macrophages via CR1
4 reasons ABO antibodies are produced under normal conditions
- Previous contact with foreign blood
- Maternal antigen exposure
- Carbohydrate antigens of intestinal microbes
- Exposure via plant pollens
Describe “hyperacute rejection” of an allogenic graft.
(timescale, mechanism)
- takes minutes - hours
- usually occurs via ABO, HLA or VEC (vascular endothelial cell antigen) incompatibility
- ex: endothelial cells express “allo-antigens” which are bound by host antibodies leading to complement activation, inflammation, endothelial damage + thrombosis
What kind of cells are involved in host vs. graft rejection?
- T cells (both CD4 + CD8)
- NK cells
- Macrophages
Describe acute rejection against an allogenic graft.
(timescale, mechanism)
- occurs up to 1 month after graft procedure
- involves endothelitis in which IgG binds alloantigens on endothelium
- delayed-type (IV) hypersensitivity occurs via CD4+ Th1, CD8+ cells + macrophages
- causes intense parenchymal damage + interstitial inflammation
- (no complement activation)
Describe chronic rejection of an allogenic graft.
(timeframe, mechanism)
- occurs months to years after the graft procedure
- causes fibrosis and vascular sclerosis
- due to a chronic type IV HS rxn, intimal SM cell proliferation will lead to vessel occlusion
- (alloantigen-specific CD4+ cells release cytokines which cause SM prolif.)
Describe the general procedure of a bone marrow graft.
- Donor (usually family) gives marrow cells via pelvic marrow harvest procedure.
- Recipient is treated with radiation and/or chemotherapy to achieve “cytoablation” (removal of their own cancerous marrow cells; also prevents HVG disease)
- Marrow transplant is applied to recipient intravenously + the transplanted hematopoietic stem cells repopulate the marrow.
What is apheresis?
How is it used in bone marrow transplantation?
- removal of a certain component of the blood + return of the remaining components to circulation
- can be used to remove HSCs from donor’s peripheral blood, rather than via painful pelvic marrow harvest
- (2-3% peripherally circulating WBCs are stem cells)
Name 3 molecules involved in the damage caused by Graft vs. Host Disease
All are CD8+ cell products…
- TNF
- FasL - binds FasR to induce apoptosis
- Perforin-Granzyme system - perforin makes hole in membrane + granzymes enter to induce apoptosis
List the target cells + organs of acute GVHD
- mostly endothelial cells are damaged
- main target organs are skin, liver, GI
- (VEC (vascular endothelial cell) antigens are highly immunogenic –> when these cells are damaged + their antigens released, further damage occurs in surrounding tissues)
What pathological changes are seen in chronic GVHD?
- fibrosis and atrophy of tissues leading to loss of function
- externally, skin color changes appear, showing up as spots on the skin
What are 2 biological rejection suppression techniques?
- Donor Selection - genotyping for immunological compatibility (family / internatn’l tranplant lists)
- Ex Vivo Graft Manipulation - suppression of immune cells in graft
What are 3 kinds of ex vivo graft manipulation?
- Steroid Infusion - graft is infused with corticosteroids to downregulate MHC expression
- Tolerance Induction - (no details on this…)
- Antibodies - e.g. anti-CD28, anti-MHCII, anti-CD4
How does cyclosporin work as a pharmaceutical rejection suppression agent?
(What other drug works this way?)
- blocks NFAT, a transcription factor for IL-2 (thus downregulation T cell proliferation)
- (FK506 also works this way)
How do azathioprineandcyclophosphoamide work in pharmacological rejection suppression?
- both block lymphocyte proliferation
- (azathioprine via purine synthesis inhibition; cyclophosphamide mechanism is… less clear)
Other than the drugs already mentioned…
what are 3 methods for pharmaceutical suppression of graft rejection?
- Monoclonal Abs - most aimed at T-cell depletion, such as anti-CD3 mAb
- Corticosteroids - such as prednisone
- Other anti-inflammatory agents
What are some (6) immunological changes seen in pregnancy?
(too much for one card… just an overview)
- Th2 shift
- HLA-G - a non-classical HLA expressed on fetal-derived placenta cells
- Blocking antibodies - bind antigens without inducing immune response, block other Abs from binding
- Decrease of CD8+ cells
- hCG and IL-6 release from placenta + female GU tract
- PIBF - leads to incr. IL-10 and decr. NK cells
What role do trophoblast cells play in the fetal antigen presentation + gestational immune tolerance?
- have no MHC-II
- have monomorphic MHC-I-like HLA-G/E molecules which:
- don’t present to CD8+ cells
- block NK cells (normally activated by MHC-I absence)
What cytokines + cell types (2) are important in immunosuppression during pregnancy?
- Th2 cytokines - block Th1 type rxns against fetus
- TGF-beta - multiple suppressive effects
- Treg - CD4+/CD25+ cells
- gamma-delta-T cells
What important transcription factor is expressed by Treg cells in the decidua during pregnancy?
Foxp3
When during pregnancy are Treg levels highest?
(this is probably not necessary, just showed up on a graph in lecture, but wasnt mentioned)
Treg levels rise slowly to a peak around week 10-11 and then decline slowly again until birth



